Aker BioMarine ASA announced its Superba krill oil approved by the Ministry of Food and Drug Safety (MFDS) in South Korea as an individually approved product with joint health claims. In late 2020, the governmental bodies in South Korea tightened the regulation on the krill oil category, effectively closing all sales of krill oil products. With the new regulation in place, all krill oil products require approval as Health Functional Food to resume sales activities in the country. The product is a formulation including krill oil with anti-inflammatory, antioxidant and joint tissue protection effects, and its scientific efficacy on joint health has been proven through animal and human application tests.

Aker BioMarine and its local partner also have Health Functional Food applications in process for other claims for Superba kill oil in South Korea. The company expects approvals of these claims as move into 2023.